Indications and uses
Helps prevent sunburn. Higher SPF gives more sunburn protection If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
Helps prevent sunburn. Higher SPF gives more sunburn protection If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
Shake well before use. Smooth over face and neck area blending well. Seal with powder if desired. Sunprotection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF of 15 or higher and other sun protection measures including: Limit time in the sun, especially from 10 a.m. –2p.m. Wear long-sleeved shirt...
Protect this product from excessive heat and direct sun.
Drug Facts
Octinoxate (5%), Octisalate (2%).
Sunscreen
Hamamelis Virginiana (Witch Hazel) Water, Cyclopentasiloxane, Titanium Dioxide (Cl 77891), Cyclomethicone, Dimethicone Crosspolymer, Cyclohexasiloxane, Butylene Glycol, Phenyl Trimethicone, Nylon-12, Hexyl Laurate, Cetyl PEG/PPG-10/1 Dimethicone, Polyglyceryl-4 Isostearate, Sodium Chloride, Aloe Barbadensis Leaf Juice, Retinyl Palmitate, Tocopheryl Acetate, Tetrahexyldecyl Ascorbate, Zea Mays (Corn) Oil, Methicone, Dimethicone, Disteardimonium Hectorite, Propylene Carbonate, Disodium EDTA, Fragrance, Phenoxyethanol, Methylparaben, Propylparaben.
Iron Oxides (CI 77491, CI 77492, CI 77499), Chromium Oxide Greens (CI 77288).
1-888-742-7626
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62839-1101-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1267-f424-e053-dadaa90a57ce | Nu Skin ® Nu Colour ® Tinted Moisturizer Broad Spectrum SPF 15 |
| 62839-1102-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1267-f424-e053-dadaa90a57ce | Nu Skin ® Nu Colour ® Tinted Moisturizer Broad Spectrum SPF 15 |
| 62839-1103-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1267-f424-e053-dadaa90a57ce | Nu Skin ® Nu Colour ® Tinted Moisturizer Broad Spectrum SPF 15 |
| 62839-1104-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1267-f424-e053-dadaa90a57ce | Nu Skin ® Nu Colour ® Tinted Moisturizer Broad Spectrum SPF 15 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62839-1101 | NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 BEIGE (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 FAIR (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 HONEY (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 SAND (OCTINOXATE AND OCTISALATE) LOTION [NSE PRODUCTS, INC.] | 2 | Legacy NDC | 20130625_55f79a4b-1654-41f7-b456-50ffdcaae845.zip |
| 62839-1102 | NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 BEIGE (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 FAIR (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 HONEY (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 SAND (OCTINOXATE AND OCTISALATE) LOTION [NSE PRODUCTS, INC.] | 2 | Legacy NDC | 20130625_55f79a4b-1654-41f7-b456-50ffdcaae845.zip |
| 62839-1103 | NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 BEIGE (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 FAIR (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 HONEY (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 SAND (OCTINOXATE AND OCTISALATE) LOTION [NSE PRODUCTS, INC.] | 2 | Legacy NDC | 20130625_55f79a4b-1654-41f7-b456-50ffdcaae845.zip |
| 62839-1104 | NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 BEIGE (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 FAIR (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 HONEY (OCTINOXATE AND OCTISALATE) LOTION NU SKIN NU COLOUR TINTED MOISTURIZER BROAD SPECTRUM SPF 15 SAND (OCTINOXATE AND OCTISALATE) LOTION [NSE PRODUCTS, INC.] | 2 | Legacy NDC | 20130625_55f79a4b-1654-41f7-b456-50ffdcaae845.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 2 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 2 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 2 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 2 | |
| .Alpha.-Tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 2 | |
| Aloe Vera Leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 2 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 2 | |
| Chromic Oxide | INACTIVE INGREDIENT | X5Z09SU859 | 2 | |
| Corn Oil | INACTIVE INGREDIENT | 8470G57WFM | 2 | |
| Cyclomethicone | INACTIVE INGREDIENT | NMQ347994Z | 2 | |
| Cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 2 | |
| Cyclomethicone 6 | INACTIVE INGREDIENT | XHK3U310BA | 2 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 2 | |
| Disteardimonium Hectorite | INACTIVE INGREDIENT | X687XDK09L | 2 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | 2 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | 2 | |
| Ferric Oxide Yellow | INACTIVE INGREDIENT | EX438O2MRT | 2 | |
| Ferrosoferric Oxide | INACTIVE INGREDIENT | XM0M87F357 | 2 | |
| Hamamelis Virginiana Top Water | INACTIVE INGREDIENT | NT00Y05A2V | 2 | |
| Hexyl Laurate | INACTIVE INGREDIENT | 4CG9F9W01Q | 2 | |
| Methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 2 | |
| Nylon-12 | INACTIVE INGREDIENT | 446U8J075B | 2 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 2 | |
| Phenyl Trimethicone | INACTIVE INGREDIENT | DR0K5NOJ4R | 2 | |
| Polyglyceryl-4 Isostearate | INACTIVE INGREDIENT | 820DPX33S7 | 2 | |
| Propylene Carbonate | INACTIVE INGREDIENT | 8D08K3S51E | 2 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 2 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| Tetrahexyldecyl Ascorbate | INACTIVE INGREDIENT | 9LBV3F07AZ | 2 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| Vitamin A Palmitate | INACTIVE INGREDIENT | 1D1K0N0VVC | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62839-1104 | 62839-1104-1 |
| 62839-1101 | 62839-1101-1 |
| 62839-1103 | 62839-1103-1 |
| 62839-1102 | 62839-1102-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / AURICULAR (OTIC) | 3 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CONCENTRATE / ORAL | 2.5 mg/5ml | ||
| Ferrosoferric Oxide | FERROSOFERRIC OXIDE | XM0M87F357 | TABLET, DELAYED RELEASE / ORAL | 6 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 0.15 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / OPHTHALMIC | 0.02 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RESPIRATORY (INHALATION) | 0.03 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | 45 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / ORAL | 432 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RESPIRATORY (INHALATION) | 43 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | LIQUID / INTRAVENOUS | 0.03 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRASYNOVIAL | 0.9 %w/v | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 19 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / PARENTERAL | 210 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | 30 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, FILM COATED / ORAL | 100 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACARDIAC | 70 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | GEL / VAGINAL | 8 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RECTAL | 0.13 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SPRAY / NASAL | 30 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 24 mg | ||
| Ferrosoferric Oxide | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE, EXTENDED RELEASE / ORAL | 1.49 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION, CONCENTRATE / ORAL | 0.2 mg/1ml | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | EMULSION / TOPICAL | 0.06 %w/w | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / ORAL | 346 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, DENTIFRICE / DENTAL | 0.03 mg/mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRA-ARTICULAR | 26 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | GEL / VAGINAL | 10 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAVENOUS | 7 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | EMULSION / TOPICAL | 0.11 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | JELLY / NASAL | NA | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / SUBCUTANEOUS | 22 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 0.4 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| Ferric Oxide Yellow | FERRIC OXIDE YELLOW | EX438O2MRT | GRANULE, FOR SUSPENSION / ORAL | 11 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, DELAYED RELEASE / ORAL | 66 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SYRUP / ORAL | 40 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVASCULAR | NA | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, DELAYED RELEASE / ORAL | 37 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SPRAY / TOPICAL | 0.8 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | ENEMA / RECTAL | 60 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INFILTRATION | 648 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE, EXTENDED RELEASE / ORAL | 0.22 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / EPIDURAL | 1 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / NASAL | 250 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / INTRAMUSCULAR | 0.13 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ORAL | 98 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | LOTION / TOPICAL | NA | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fd4d2ced-c196-4b9b-a2fb-9cc953947b52 | 55f79a4b-1654-41f7-b456-50ffdcaae845 | 2026-03-31 | Warnings | 55f79a4b-1654-41f7-b456-50ffdcaae845 |
Adverse event summaries are temporarily unavailable. Other product information remains available.